Rep. Ccanady reintroduces bill to provide unlimited coverage of immunosuppressive drugs From: Transplant News | Date: April 29, 1997 | COPYRIGHT 1997 Transplant Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Representative Charles Canaday (R-FL) has reintroduced a bill in the U.S. House of Representatives to eliminate the time limitation on benefits for immunosuppressive drugs under the medicare program.

Canaday introduced the legislation, H.R. 1061, in March last year after he was contacted by a constituent, Dave Berry, who had received a kidney transplant only to find his health insurance was running out and Medicare would not pay for his immunosuppressive drugs.

Berr...

Related newspaper, magazine, and journal articles from HighBeam Research

	Rep. Ccanady reintroduces bill to provide unlimited coverage of immunosuppressive drugs Transplant News ; ... necessary to ensure that the transplants are a success, Canaday said in a press release introducing the legislation. As Transplant News went to press, Canaday had sixteen co-sponsors for H.R. 1061. They include: Frederick Boucher (D-VA); John Cooksey (R-LA); Philip ...
	DEWINE CONTINUES WORK TO EXTEND GIFT OF LIFE TO ORGAN TRANSPLANT RECIPIENTS Capitol Hill Press Releases ; 00-00-0000 FOR IMMEDIATE RELEASE: DECEMBER 15, 2000 DEWINE CONTINUES WORK TO EXTEND GIFT OF LIFE TO ORGAN TRANSPLANT RECIPIENTS Legislation to help those who receive Medicare-eligible organ transplants maintain access to immunosuppressive drugs heads to White House U.S. Senator Mike DeWine (R-OH)
	DEWINE CONTINUES WORK TO EXTEND GIFT OF LIFE TO ROGAN TRANSPLANT RECIPIENTS Capitol Hill Press Releases ; 00-00-0000 DECEMBER 15,2000 DEWINE CONTINUES WORK TO EXTEND GIFT OF LIFE TO ORGAN TRANSPLANT RECIPIENTS Legislation to help those who receive Medicare- eligible organ transplants maintain access to immunosuppressive drugs heads to White House U.S. Senator Mike DeWine (R-OH) today announced final
	DEWINE BILL EXTENDS GIFT OF LIFE TO ORGAN TRANSPLANT RECIPIENTS Capitol Hill Press Releases ; ... Joining House members who support the companion bill, and liver transplant recipient and actor Larry Hagman at a Capitol Hill news conference, Senator DeWine reintroduced the Immunosuppressive Drug Coverage Act to ensure that those receiving Medicare covered ...
	Procedure reverses insulin-dependent diabetes in a primate without immunosuppressive drugs. Biomedical Materials ; Researchers in Massachusetts, USA, say they have successfully transplanted primate islet cells into a mismatched diabetic primate without having to use long-term immunosuppressive drugs. The recipient animal's insulin-dependent diabetes was completely reversed by the procedure, and remained
	Legislation providing unlimited coverage of immunosuppressives introduced by Rep. Canady Transplant News ; ... Committee on Ways and Means and to the Committee on Commerce for a period to be subsequently determined by the Speaker. As Transplant News went to press, H.R. 3138 had four co-sponsors, according to Rep. Canady's staff. They include Reps: W.G. Hefner (D-NC), William ...
	Oral immunosuppressive drugs Clinical Medicine ; KEY WORDS: azathioprine, ciclosporin, mycophenolate, oral immunosuppressive drugs Understanding the immune network The last few decades have witnessed remarkable achievements in the development of immunosuppressive drugs, made possible by significant advances in molecular immunology and improved
	War on diabetes gets boost - New Harvard center to pursue cure for kids. The Boston Herald ; A cure for juvenile diabetes is the goal of a new research center to be established at Harvard Medical School with a $20 million grant being announced today. The grant, from the Juvenile Diabetes Foundation, will fund 32 researchers over five years as they seek a way to allow those with juvenile
	Are antirejection drugs on the endangered list? Drug Topics ; CLINICAL PRACTICE Transplant patients may one day be completely free from grueling regimens of immunosuppressive drugs, according to researchers from India, Stanford University, and the University of Pittsburgh. The investigators presented findings from three studies at the recent 19th
	Flu vaccine less effective in SLE.(CLINICAL CAPSULES)(systemic lupus erythematosus)(Brief article) Internal Medicine News ; Influenza vaccination appears to be safe in patients with quiescent systemic lupus erythematosus, but may be less effective than in healthy controls, reported Dr. A. Holvast of the University of Groningen, the Netherlands, and colleagues. They studied 56 SLE patients with quiescent disease who were

See all results.